REGENXBIO

+$0.85 (+3.42%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.

About RGNX

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors; and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.

CEO
Kenneth T. Mills
Employees
306
Headquarters
Rockville, Maryland
Founded
2008

RGNX Key Statistics

Market cap
1.10B
Price-Earnings ratio
—
Dividend yield
—
Average volume
384.44K
High today
$25.74
Low today
$24.28
Open price
$24.62
Volume
312.00K
52 Week high
$49.50
52 Week low
$24.14

RGNX Earnings

-$1.37
-$0.84
-$0.30
$0.23
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 1, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure